Literature DB >> 9727847

Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease.

R G Boles1, T Roe, D Senadheera, V Mahnovski, L J Wong.   

Abstract

UNLABELLED: Kearns Sayre syndrome (KSS) is a multisystem disorder with a confounding variety of clinical manifestations, including ocular myopathy, pigmentary retinopathy, heart block and ataxia. Endocrinopathies are common in KSS, including growth hormone deficiency, hypogonadism, diabetes mellitus and hypoparathyroidism. A variety of deletions of mitochondrial DNA (mtDNA) are found in most cases. We report on a 5-year-old boy with Addison disease in whom further investigation revealed a 4.9 kilobase mtDNA deletion and KSS. Later he developed severe lactic acidosis and expired.
CONCLUSION: The degree of mutant mtDNA heteroplasmy in various tissues on autopsy did not correlate well with the clinical manifestations, although this may be due at least in part to replacement with other tissue types. Our report is the first of non-autoimmune Addison disease in KSS and patients with KSS should be evaluated for adrenal insufficiency. Early recognition of adrenal insufficiency is crucial to prevent mortality from this cause.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727847     DOI: 10.1007/s004310050902

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  [Characteristics of anesthesia in patients with MELAS syndrome: Case report of anesthesia in video-assisted thoracoscopy].

Authors:  A Haas; F Wappler
Journal:  Anaesthesist       Date:  2015-08-28       Impact factor: 1.041

Review 2.  An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

3.  Large mitochondrial DNA deletion in an infant with addison disease.

Authors:  Gloria P Duran; A Martinez-Aguayo; H Poggi; M Lagos; D Gutierrez; P R Harris
Journal:  JIMD Rep       Date:  2011-09-22

4.  Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion.

Authors:  Michael J O'Grady; Ahmad A Monavari; Melanie Cotter; Nuala P Murphy
Journal:  BMJ Case Rep       Date:  2015-02-26

5.  A rare case report of simultaneous presentation of myopathy, Addison's disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome.

Authors:  Meropi Tzoufi; Alexandros Makis; Nikolaos Chaliasos; Iliada Nakou; Ekaterini Siomou; Agathoklis Tsatsoulis; Anastasia Zikou; Maria Argyropoulou; Jean Paul Bonnefont; Antigone Siamopoulou
Journal:  Eur J Pediatr       Date:  2012-08-09       Impact factor: 3.183

Review 6.  The role of suboptimal mitochondrial function in vulnerability to post-traumatic stress disorder.

Authors:  Graeme Preston; Faisal Kirdar; Tamas Kozicz
Journal:  J Inherit Metab Dis       Date:  2018-03-28       Impact factor: 4.982

Review 7.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

Review 8.  Endocrine manifestations related to inherited metabolic diseases in adults.

Authors:  Marie-Christine Vantyghem; Dries Dobbelaere; Karine Mention; Jean-Louis Wemeau; Jean-Marie Saudubray; Claire Douillard
Journal:  Orphanet J Rare Dis       Date:  2012-01-28       Impact factor: 4.123

9.  Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.

Authors:  Alejandro Horga; Robert D S Pitceathly; Julian C Blake; Catherine E Woodward; Pedro Zapater; Carl Fratter; Ese E Mudanohwo; Gordon T Plant; Henry Houlden; Mary G Sweeney; Michael G Hanna; Mary M Reilly
Journal:  Brain       Date:  2014-10-03       Impact factor: 13.501

Review 10.  Endocrine disorders in mitochondrial disease.

Authors:  Andrew M Schaefer; Mark Walker; Douglass M Turnbull; Robert W Taylor
Journal:  Mol Cell Endocrinol       Date:  2013-06-13       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.